HCA Healthcare, Inc. $HCA Stock Position Lowered by NFJ Investment Group LLC

NFJ Investment Group LLC lessened its position in HCA Healthcare, Inc. (NYSE:HCA) by 25.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 53,834 shares of the company’s stock after selling 17,969 shares during the quarter. NFJ Investment Group LLC’s holdings in HCA Healthcare were worth $25,133,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in the stock. Sumitomo Life Insurance Co. increased its stake in HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after buying an additional 20 shares during the period. MJP Associates Inc. ADV increased its stake in HCA Healthcare by 2.9% in the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after buying an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC increased its stake in HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after buying an additional 21 shares during the period. Cary Street Partners Financial LLC increased its stake in HCA Healthcare by 3.9% in the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after buying an additional 22 shares during the period. Finally, Plato Investment Management Ltd increased its stake in HCA Healthcare by 0.6% in the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after buying an additional 22 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of several research reports. Royal Bank Of Canada dropped their price objective on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. JPMorgan Chase & Co. dropped their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 19th. KeyCorp dropped their price target on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Truist Financial set a $413.00 price target on shares of HCA Healthcare in a research note on Thursday, June 4th. Finally, Weiss Ratings lowered shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $506.14.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $387.25 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The firm has a fifty day moving average price of $429.60 and a two-hundred day moving average price of $473.48. The company has a market cap of $85.91 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the company earned $6.45 earnings per share. HCA Healthcare’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.